7th Eurasian Hematology Oncology Summit

 

7th Eurasian Hematology Oncology Summit
T

2020 Update on IO in R/R cHL: Is Long-Term Therapy w/ Nivo Feasible and Safe?

By 7th Eurasian Hematology Oncology Summit FEATURING Tulin Tuglular
By 7th Eurasian Hematology Oncology Summit FEATURING Tulin Tuglular
136 views
September 30, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

19:25
Pfizer Hematology

Moving Forward in Stage III/IV Classical Hodgkin Lymphoma

Feat. A. Ip
Lymphoma
14:50

How I Treat Follicular Lymphoma in 2020: Rituximab vs. WW Strategy, …

7th Eurasian Hematology Oncology Summit

G. Gaidano

60 views
19:51

How I Treat DLBCL in 2020: Can Radiotherapy Be Omitted in PET Era? I…

7th Eurasian Hematology Oncology Summit

U. Vitolo

46 views
23:29

2020 Update on IO in R/R cHL: Is Long-Term Therapy w/ Nivo Feasible …

7th Eurasian Hematology Oncology Summit

T. Tuglular

136 views
15:27

How I Treat HL in 2020: What Is the Role of PET-Adapted Strategies? …

7th Eurasian Hematology Oncology Summit

C. Gisselbrecht

200 views
21:20

How I Treat Mantle Cell Lymphoma in 2020: Induction Options, ASCT, a…

7th Eurasian Hematology Oncology Summit

C. Schiffer

694 views